<p>Over an eighteen month period 53 cases were contacted. The parents of five children chose not to participate. For the remaining 48 cases written informed consent was obtained. Thirty-seven of the 48 infants were seen three times. Of the remaining eleven, two were seen twice, at one week and one month, and the third visit was canceled by the parents because of good recovery. Eight were seen relatively late, so they were only seen at one and three months. One infant was only seen at one week because of good recovery afterwards. Not attended visits were regarded as missing data. The mean age at visit one was 9 days (median 9, range 12), at visit two 32 days (median 31, range 29) and at visit three 87 days (median 87, range 29).</p
<p>Flow diagram showing number of infants recruited and those who were lost to follow-up.</p
<p>In the analysis of time to first infection and clinical episode, children were censored on the la...
<p>The numbers of individuals enrolled by age, followed by elimination of individuals with TB, HIV i...
<p>Infants who were absent more than 3 consecutive months, and not seen before their 12 months were ...
<p>Lost to follow up = patients tested at birth but who did not attend routine early infant diagnosi...
<p>The number of patients and visits at each year of the study are reported into brackets. Five pati...
<p>Due to the repeated measures design of the present study, enrollment of consecutive infants was n...
<p>* Includes one new HIV-infection observed at six months for an infant who was not tested at one m...
There was no apparent difference in premature study discontinuation for reasons other than death; 23...
<p>Exclusion criteria were age <14 years, pregnancy, clinician excluded, premedication given, prior ...
<p>During the study period (i.e. day of life 4 until day of life 28), 25 infants were evaluated for ...
<p>Of 10,463 patients approached for inclusion in study, 8,715 consented. Because patients were retr...
<p>Diagram indicating the numbers of infants screened and followed up throughout the study.</p
<p><sup>1</sup>Includes all children in school years 1 to 6 (generally aged from 5 to 11 y). The num...
<p>All children admitted to hospital fitting WHO criteria for AES who were alive at discharge were a...
<p>Flow diagram showing number of infants recruited and those who were lost to follow-up.</p
<p>In the analysis of time to first infection and clinical episode, children were censored on the la...
<p>The numbers of individuals enrolled by age, followed by elimination of individuals with TB, HIV i...
<p>Infants who were absent more than 3 consecutive months, and not seen before their 12 months were ...
<p>Lost to follow up = patients tested at birth but who did not attend routine early infant diagnosi...
<p>The number of patients and visits at each year of the study are reported into brackets. Five pati...
<p>Due to the repeated measures design of the present study, enrollment of consecutive infants was n...
<p>* Includes one new HIV-infection observed at six months for an infant who was not tested at one m...
There was no apparent difference in premature study discontinuation for reasons other than death; 23...
<p>Exclusion criteria were age <14 years, pregnancy, clinician excluded, premedication given, prior ...
<p>During the study period (i.e. day of life 4 until day of life 28), 25 infants were evaluated for ...
<p>Of 10,463 patients approached for inclusion in study, 8,715 consented. Because patients were retr...
<p>Diagram indicating the numbers of infants screened and followed up throughout the study.</p
<p><sup>1</sup>Includes all children in school years 1 to 6 (generally aged from 5 to 11 y). The num...
<p>All children admitted to hospital fitting WHO criteria for AES who were alive at discharge were a...
<p>Flow diagram showing number of infants recruited and those who were lost to follow-up.</p
<p>In the analysis of time to first infection and clinical episode, children were censored on the la...
<p>The numbers of individuals enrolled by age, followed by elimination of individuals with TB, HIV i...